LX-2761

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLX-2761
Drug Alias NameLX-2761
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 1 inhibitorsSodium/glucose cotransporter 2 inhibitors
TargetsSodium/glucose cotransporter 2Sodium/glucose cotransporter 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLexicon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesLexicon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A